Stock EPN EPSILON HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Epsilon Healthcare Limited

Equities

EPN

AU0000137598

Pharmaceuticals

Market Closed - Australian S.E.
Other stock markets
 06:37:33 2023-12-17 pm EST 		5-day change 1st Jan Change
0.024 AUD -.--% Intraday chart for Epsilon Healthcare Limited -.--% -.--%
2023 Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting CI
2023 Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting CI

Business Summary

Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Company’s segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Company’s subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.

Sales per Business

AUD in Million2021Weight2022Weight Delta
Medicinal Cannabis
59.8 %
3 48.5 % 4 59.8 % +59.45%
Hydroponics Equipment, Materials and Nutrients
40.2 %
3 51.5 % 3 40.2 % +1.03%

Sales per region

AUD in Million2021Weight2022Weight Delta
Australia
59.8 %
3 48.5 % 4 59.8 % +59.45%
Canada
40.2 %
3 51.5 % 3 40.2 % +1.03%

Managers

Managers TitleAgeSince
Daniel Sanghera CEO
 Chief Executive Officer - Nov. 20
Lin Li AUD
 Comptroller/Controller/Auditor - -
Marcelo Mora SEC
 Corporate Secretary 60 22-12-22

Members of the board

Members of the board TitleAgeSince
Alan Beasley CHM
 Chairman - 16-08-28
Stuart Cameron BRD
 Director/Board Member - 22-10-26
Xiao Cui CHM
 Chairman - 22-10-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 300,354,011 181,387,905 ( 60.39 %) 0 60.39 %

Shareholders

NameEquities%Valuation
Evolve Funds Group, Inc.
0.0234 %
70,237 0.0234 % 1 128 $

Company contact information

Epsilon Healthcare Ltd.

9 Castlereagh Street Level 17

2000, Sydney

+

http://www.epsilonhealthcare.com.au
address Epsilon Healthcare Limited(EPN)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
EPSILON HEALTHCARE LIMITED Stock Epsilon Healthcare Limited
-.--% 4.77M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. EPN Stock
  4. Company Epsilon Healthcare Limited